4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001415889-23-000289
Options or other derivatives
- PRESIDENT AND HEAD OF R&D acquired 136,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huber Martin H. Jr. · PRESIDENT AND HEAD OF R&D
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-01-01 | Grant or award : show line 1 in the form Stock Option (right to buy) | +136,500 | 136,500 | D |
Loading xslF345X03/form4-01042023_090139.xml…